Skip to main content
Clinical Trials/JPRN-UMIN000018244
JPRN-UMIN000018244
Completed
未知

Research Study in Patients With COPD in High Risk Population in Japan: Proportion of Overlap Between COPD and Asthma, and the Relationship With COPD Exacerbatio

AstraZeneca K.K.0 sites1,100 target enrollmentJuly 8, 2015
ConditionsCOPD

Overview

Phase
未知
Intervention
Not specified
Conditions
COPD
Sponsor
AstraZeneca K.K.
Enrollment
1100
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 8, 2015
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with a diagnosis of COPD (FEV1/FVC\<0\.7 confirmed based on the past medical records)
  • \-Patients aged 40 years and over at the diagnosis of COPD
  • \-Outpatient
  • \-10 or more pack\-years of current or former smokers
  • \-Patients who have traceable medical records of COPD (including the results of spirometry) going back more than a year
  • \-Patients who meet any of the following two criteria
  • 1\.Patients who have medical records of the results of spirometry at more than two different time points excluding the time point of COPD exacerbations\* for the past 3 years
  • 2\.Patients who can provide the results of reversibility testing for respiratory tract
  • \-Patients who give written informed consent regarding the participation in this study

Exclusion Criteria

  • \-Patients currently with COPD exacerbations
  • \-Patients who currently enroll in the other interventional study including clinical trials
  • \-Patients who concurrently develop or have a history of lung cancer
  • \-Patients who are disabled to understand the study procedure or answer the questionnaire (i.e. due to the history of alcohol or drug abuse)

Outcomes

Primary Outcomes

Not specified

Similar Trials